Systemic inflammation in absence of gut bacterial translocation in C57BL/6 mice with cirrhosis

Gut

Volumn 62, Issue 2, 2013, Pages 330-331

  Úbeda, María ^a,b   Lario, Margaret ^a,b   Muñoz, Leticia ^a,b   Díaz, David ^a,b   Borrero, María José ^a,b   García Bermejo, Laura ^c   Álvarez Mon, Melchor ^a,b,d   Albillos, Agustín ^a,b,c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CARBON TETRACHLORIDE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL GROWTH; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; IMMUNE SYSTEM; LETTER; LIVER CIRRHOSIS; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANTI-BACTERIAL AGENTS; HUMANS; LIVER CIRRHOSIS; PERITONITIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84872093247     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-302920     Document Type: Letter

References (10)

1. Wiest R, Krag A, Gerbes A. Spontaneus bacterial peritonitis: recent guidelines and beyond. Gut 2012;61:297-310.
2. Albillos A, de la Hera A, Alvarez Mon M. Experimental models of spontaneous bacterial peritonitis. In: Ginés P, Arroyo V, Rodés J, et al. Ascites and Renal Dysfunction in Liver Disease. Oxford: Blackwell Publishing, 2005:411-21.
3. Muñoz L, Albillos A, Nieto M, et al. Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis. Hepatology 2005;42:411-19. (Pubitemid 41061094)
4. Úbeda M, Muñoz L, Borrero MJ, et al. Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis. Hepatology 2010;52:2086-95.
5. Albillos A, Nieto M, Úbeda M, et al. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. Gut 2010;59:943-52.
6. Albillos A, Hera Ad Ade L, Reyes E, et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004;40:624-31. (Pubitemid 38367784)
7. Devière J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-34. (Pubitemid 20151741)
8. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
9. Zimmermann HW, Seidler S, Nattermann J, et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010;5:e11049.
10. Pérez-Páramo M, Muñoz J, Albillos A, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;31:43-8. (Pubitemid 30033687)